Finish Line Stumbles Over Missed Earnings and Guidance
Finish Line reported disappointing fiscal third-quarter financial results before the markets opened on Wednesday.
Finish Line reported disappointing fiscal third-quarter financial results before the markets opened on Wednesday.
Inovio Pharmaceuticals shares saw a handy gain on Wednesday after the company reported positive results from its early-stage Zika trial.
Micron Technology is scheduled to release its fiscal first-quarter financial results after the markets close on Wednesday.
The SEC has announced that an Oklahoma-based oil-and-gas company has agreed to settle charges that it used illegal separation agreements and retaliated against a whistleblower.
FedEx reported mixed fiscal second-quarter financial results after the markets closed on Tuesday.
Nike Inc. (NYSE: NKE) reported fiscal second-quarter financial results after markets closed on Tuesday. The company posted $0.50 in earnings per share (EPS) and $8.2 billion in revenue. The consensus estimates from Thomson Reuters…
The U.S. Securities and Exchange Commission (SEC) recently announced that a technology company has agreed to pay a penalty of $180,000 to settle charges involving its severance agreements that impeded at least one former…
Nike is scheduled to report its fiscal second-quarter financial results after the markets close on Tuesday.
Akebia Therapeutics shares saw a handy gain on Tuesday after the company reported a new collaboration with Otsuka Pharmaceutical.
The SEC has charged the founder of Platinum Partners and two of its flagship hedge fund advisory firms with conducting a fraudulent scheme to inflate asset values.
CarMax released a mixed fiscal third-quarter earnings report before the markets opened on Tuesday.
BlackBerry reported disappointing fiscal third-quarter financial results before the markets opened on Tuesday.
Jagged Peak Energy has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Conatus Pharmaceuticals saw its shares more than double early on Tuesday after the company reported an exclusive collaboration and license agreement for its cirrhosis treatment.
Clovis Oncology, Inc. (NASDAQ: CLVS) is watching its shares hit a new 52-week high after the company reported a key U.S. Food and Drug Administration (FDA) approval. Essentially, the FDA approved Rubraca (rucaparib) tablets…
The U.S. Securities and Exchange Commission (SEC) recently announced that it has settled cease-and-desist proceedings against the CEO of a Utah-based broker-dealer and two registered persons associated with the firm for causing the firm’s…
BlackBerry Limited (NASDAQ: BBRY) is scheduled to report fiscal third-quarter financial results before the markets open on Tuesday. The consensus estimates from Thomson Reuters are calling for a net loss of $0.01 per share…
IC Power PTE has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Portola Pharmaceuticals shares saw a handy gain on Monday after it was reported that the company had received a key loan.
The SEC has barred several market participants from the penny stock industry for their roles in various sham initial public offerings of microcap stocks that defrauded investors.